Rodney W. Lappe, Director at Design Therapeutics, Inc. (DSGN), bought 5,000 shares at $20.00 ($100K) on 2021-03-30, disclosed to the SEC on 2021-04-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |